Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Re: Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Khosrow-Khavar F, Kurteva S, Douros A.

J Natl Cancer Inst. 2019 Apr 24. pii: djz066. doi: 10.1093/jnci/djz066. [Epub ahead of print] No abstract available.

PMID:
31020327
2.

Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study.

Douros A, Tölle M, Ebert N, Gaedeke J, Huscher D, Kreutz R, Kuhlmann MK, Martus P, Mielke N, Schneider A, Schuchardt M, van der Giet M, Schaeffner E.

Eur Heart J. 2019 Feb 25. pii: ehz071. doi: 10.1093/eurheartj/ehz071. [Epub ahead of print]

PMID:
30805599
3.

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L.

Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25.

PMID:
30691551
4.

What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.

Sommet A, Bénévent J, Rousseau V, Chebane L, Douros A, Montastruc JL, Montastruc F.

J Gen Intern Med. 2019 Apr;34(4):502-503. doi: 10.1007/s11606-018-4774-2. No abstract available.

PMID:
30565153
5.

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OH, Faillie JL, Montastruc F, Platt RW, Bouganim N, Azoulay L.

BMJ. 2018 Dec 5;363:k4880. doi: 10.1136/bmj.k4880.

6.

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L.

Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27.

PMID:
30150234
7.

Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L.

Epidemiology. 2018 Nov;29(6):904-912. doi: 10.1097/EDE.0000000000000891.

PMID:
30028343
8.

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S.

BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693.

9.

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L.

BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872.

10.

Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review.

Douros A, Ades M, Renoux C.

CNS Drugs. 2018 Apr;32(4):321-334. doi: 10.1007/s40263-018-0507-7. Review.

PMID:
29536379
11.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

12.

Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study
.

Douros A, Bronder E, Klimpel A, Erley C, Garbe E, Kreutz R.

Clin Nephrol. 2018 Jan;89 (2018)(1):18-26. doi: 10.5414/CN109212.

PMID:
29035197
13.

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.

Douros A, Renoux C, Coulombe J, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.

PMID:
28984052
14.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
15.

Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.

Kreutz R, Scholze J, Douros A.

Curr Vasc Pharmacol. 2018 Jan 26;16(2):197-203. doi: 10.2174/1570161115666170821155555.

PMID:
28828980
16.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
17.

Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.

Douros A, Jobski K, Kollhorst B, Schink T, Garbe E.

Br J Clin Pharmacol. 2016 Sep;82(3):839-48. doi: 10.1111/bcp.13019. Epub 2016 Jun 22.

18.

Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E114. doi: 10.3390/ijms17010114.

19.

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015;11(12):1849-59. doi: 10.1517/17425255.2015.1098617. Epub 2015 Oct 12. Review. Erratum in: Expert Opin Drug Metab Toxicol. 2015;11(12):v.

PMID:
26457865
20.

Estimating kidney function and use of oral antidiabetic drugs in elderly.

Douros A, Ebert N, Jakob O, Martus P, Kreutz R, Schaeffner E.

Fundam Clin Pharmacol. 2015 Jun;29(3):321-8. doi: 10.1111/fcp.12118. Epub 2015 Apr 17.

PMID:
25817734
21.

Erratum to: flupirtine-induced liver injury--seven cases from the Berlin Case-Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E.

Eur J Clin Pharmacol. 2015 Mar;71(3):387. doi: 10.1007/s00228-015-1810-6. No abstract available.

PMID:
25604511
22.

Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Sarganas G, Kreutz R, Garbe E.

Br J Clin Pharmacol. 2015 Jun;79(6):988-99. doi: 10.1111/bcp.12565.

23.

Safety issues and drug-drug interactions with commonly used quinolones.

Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39. doi: 10.1517/17425255.2014.970166. Epub 2014 Nov 26. Review.

PMID:
25423877
24.

Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E.

Eur J Clin Pharmacol. 2014 Apr;70(4):453-9. doi: 10.1007/s00228-013-1631-4. Epub 2013 Dec 24. Erratum in: Eur J Clin Pharmacol. 2015 Mar;71(3):387.

PMID:
24366502
25.

Ramipril-induced liver injury: case report and review of the literature.

Douros A, Kauffmann W, Bronder E, Klimpel A, Garbe E, Kreutz R.

Am J Hypertens. 2013 Sep;26(9):1070-5. doi: 10.1093/ajh/hpt090. Epub 2013 Jun 8. Review.

PMID:
23747952

Supplemental Content

Loading ...
Support Center